David Norwood

David Norwood graduated with a degree in history from Keble college, Oxford and went on to establish the IP Group in England focused on seed-stage investments and licensing of IP stemming from academic institutions. He was the former CEO of the Oxford Science Innovation (OSI) fun, one of the largest funds worldwide focused on early […]

Ruilin Song

Mr. Song holds a bachelor degree in law from the China University of Political Science and Law and an MBA from the China Europe International Business School. He is now an executive chairman of the China Association for the Promotion of Pharmaceutical Innovation and deputy executive director of the National Center for Pharmaceutical Policy and […]

Yuk Lam Lo

Professor Lo has experience in many fields such as biotechnology, corporate management, academic research and community service. He is the independent non-executive director of Luye Pharmaceuticals(HKEX:2186) and CSPC(HKEX:1093), independent director of Sinovac Biotech(Nasdaq: SVA), director of Hong Kong Baptist University, executive vice president of Asia College, and Lo’s Associates’ chairman. Professor Lo is currently the […]

Keith Lenden

Keith is a venture partner at ARCH Ventures and a seasoned entrepreneur and leader in the biotechnology and pharmaceutical space with a proven track record in company formation, executive and project leadership, business and corporate development, alliance management,and corporate and market strategy. Keith was a co-founder of Receptos, Inc., a S1P1 biology and GPCR drug […]

Honggang Bi, Ph.D.

Dr. Honggang Bi is Senior Vice President, Drug Development Head, APAC, and General Manager, China. Honggang provides executive oversight of both operations and customer relationships, representing Drug Development business lines, as well as LabCorp’s emerging Diagnostics presence in Asia Pacific (except India). Honggang drives enterprise growth strategies in the region, leveraging the Power of the […]